Cargando…
Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing
Several repurposed drugs are currently under investigation in the fight against coronavirus disease 2019 (COVID-19). Candidates are often selected solely by their effective concentrations in vitro, an approach that has largely not lived up to expectations in COVID-19. Cell lines used in in vitro exp...
Autores principales: | Kern, Charlotte, Schöning, Verena, Chaccour, Carlos, Hammann, Felix |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988345/ https://www.ncbi.nlm.nih.gov/pubmed/33776767 http://dx.doi.org/10.3389/fphar.2021.625678 |
Ejemplares similares
-
Effectiveness of Antiviral Therapy in Highly-Transmissible Variants of SARS-CoV-2: A Modeling and Simulation Study
por: Schöning, Verena, et al.
Publicado: (2022) -
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
por: Chen, Catherine Z., et al.
Publicado: (2021) -
Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease
por: Pinzi, Luca, et al.
Publicado: (2021) -
A review of SARS-CoV-2 drug repurposing: databases and machine learning models
por: Elkashlan, Marim, et al.
Publicado: (2023) -
Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen
por: Rodon, Jordi, et al.
Publicado: (2021)